SCHEMBL19851022

SCHEMBL19851022

CCOC(=O)CSc1nc2cccnc2n1-c1ccc(C2CC2)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
LMNA P02545 1/20 0.58
SMN1; SMN2 Q16637 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
ALDH1A1 P00352 4/20 0.51
MAPK1 P28482 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 1/20 0.51
KDM4E B2RXH2 2/20 0.49
HPGD P15428 2/20 0.49
POLB P06746 1/20 0.49
PDE10A Q9Y233 1/20 0.48
ALOX15 P16050 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
SLC22A12 Q96S37 2/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851016 0.90 TSHR (0.47) TSHRLMNASMN1; SMN2NPSR1ALDH1A1
SCHEMBL19851026 0.87 SLC22A12 (0.62) ALDH1A1MAPK1HPGDPOLBCYP1A2
SCHEMBL19851100 0.86 TSHR (0.66) TSHRLMNASMN1; SMN2NPSR1ALDH1A1
SCHEMBL19851023 0.86 SLC22A12 (0.59) TSHRLMNANPSR1ALDH1A1MAPK1
SCHEMBL19851131 0.86 SLC22A12 (0.64) TSHRLMNASMN1; SMN2NPSR1ALDH1A1
SCHEMBL19851024 0.85 SLC22A12 (0.60) TSHRLMNAALDH1A1MAPK1MAPT
SCHEMBL21093644 0.85 SLC22A12 (0.48) ALDH1A1MAPK1HPGDPOLBCYP1A2
SCHEMBL19851029 0.83 SLC22A12 (0.65) TSHRSMN1; SMN2NPSR1ALDH1A1L3MBTL1
SCHEMBL19851127 0.82 SLC22A12 (0.45) ALDH1A1MAPK1HPGDPOLBCYP1A2
SCHEMBL19851017 0.80 SLC22A12 (0.53) ALDH1A1MAPK1HPGDPOLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2731/4885LMNA 4231/4885SMN1; SMN2 4188/4885
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2444/4885LMNA 3991/4885SMN1; SMN2 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.